BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX

Rank in Stocks #24403
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.29374943
Last synced: 2026-11-17
Market Cap
$31.24M
Change (1 day)
-0.20%
Change (1 year)
16.70%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for BioMark Diagnostics Inc. (BUX)
Operating Margin as of November 2026 TTM: -6,782.46%
According to BioMark Diagnostics Inc.'s latest financial reports, its current operating margin (TTM) is -6,782.46%. At the end of 2025 the company had an operating margin of -1,237.31%.
Operating Margin history for BioMark Diagnostics Inc. from 2014 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -6,782.46% 448.16%
2025 -1,237.31% 53.38%
2024 -806.71% -32.72%
2023 -1,198.95% -58.98%
2022 -2,922.50% 0.00%
2021 0.00% -100.00%
2020 -449.31% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.98% -100.00%
US
20.38% -100.00%
US
43.02% -100.01%
CN
32.30% -100.00%
US
22.23% -100.00%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about BioMark Diagnostics Inc.'s operating margin

What is BioMark Diagnostics Inc.'s operating margin?

BioMark Diagnostics Inc.'s operating margin is -6,782.46%, as of Nov 2026.

What was BioMark Diagnostics Inc.'s operating margin in 2025?

In 2025, BioMark Diagnostics Inc.'s operating margin was -1,237.31%, compared with -806.71% in 2024.

How has BioMark Diagnostics Inc.'s operating margin changed since 2020?

From 2020 to 2025, BioMark Diagnostics Inc.'s operating margin was highest in 2021 (0.00%) and lowest in 2022 (-2,922.50%).

How does BioMark Diagnostics Inc.'s operating margin compare with similar companies?

BioMark Diagnostics Inc.'s operating margin (-6,782.46%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.